Layla review
Standing monthly rates of $199 for compounded semaglutide and $299 for compounded tirzepatide, each fronted by a $99 first-month promotion that is the number the marketing actually leads with. Read live on 2026-08-21, the plan cards say it plainly — "Starting at $99 / 1st Month (Originally $199 / month)" — so the discount is real and it lasts exactly one month. Two things sit alongside it that a reader should see. Quarterly plans are also offered at $297 and $449 and are labeled per month on the card, which cannot be reconciled against the cheaper monthly plans from the public page alone, so those figures are not asserted here. And the page was running a Cyber Week banner with a fifty-percent-off countdown reading zero hours, zero minutes and zero seconds — in August. Against that, its disclosure is better than most: three operating entities are named, including the prescribing practices Beluga Health, P.A. and Pennsylvania Medical, P.C., and all three screened clean against the full live FDA warning-letter index.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Layla at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not stated on the site
- Brand-name
- Compounded only
How we scored Layla
Each score comes out of Layla's published pricing, disclosures and oversight, and the six combine into the 41/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The headline rate obscures a plan requirement or a hidden step-up.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
Little here is shaped around a mother's week or her life stage.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- joinlayla.com
Standing rates are $199 for semaglutide and $299 for tirzepatide, each discounted to $99 for a first month. The 08-17 note that it "starts at $1299" was not a monthly figure. A Cyber Week countdown was running in August, stopped at zero.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | InjectionRead live 2026-08-21 on /weight-loss: the monthly plan card reads "Starting at $99 / 1st Month (Originally $199 / month)". The STANDING rate is $199; $99 is a first-month promotion. ⛔ CORRECTS the 08-17 screening sheet, which recorded "starts at $1299" — that is not the monthly rate. |
| Compounded tirzepatide | $299 | InjectionRead live 2026-08-21: "Starting at $99 / 1st Month (Originally $299 / month)". Standing rate $299, first month $99. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Layla's public disclosures at last review and change often; confirm the current number on Layla's own site.
What we like
- Standing monthly rates are published on the plan cards rather than only the promotional first month
- Names three operating entities including its prescribing practices, Beluga Health, P.A. and Pennsylvania Medical, P.C.
- All three entities screened clean against the full live FDA warning-letter index
The caveats
- A "Cyber Week" banner and a "50% off, ends in" countdown reading 00:00:00 were running in August — manufactured urgency
- Quarterly plans are labeled per-month at $297 and $449, which cannot be reconciled with the cheaper monthly plans from the public page
- The headline everywhere is the $99 first month, not the $199 and $299 you actually pay from month two
- No state list published
Layla for mothers: our verdict
Standing monthly rates of $199 for compounded semaglutide and $299 for compounded tirzepatide, each fronted by a $99 first-month promotion that is the number the marketing actually leads with. Read live on 2026-08-21, the plan cards say it plainly — "Starting at $99 / 1st Month (Originally $199 / month)" — so the discount is real and it lasts exactly one month. Two things sit alongside it that a reader should see. Quarterly plans are also offered at $297 and $449 and are labeled per month on the card, which cannot be reconciled against the cheaper monthly plans from the public page alone, so those figures are not asserted here. And the page was running a Cyber Week banner with a fifty-percent-off countdown reading zero hours, zero minutes and zero seconds — in August. Against that, its disclosure is better than most: three operating entities are named, including the prescribing practices Beluga Health, P.A. and Pennsylvania Medical, P.C., and all three screened clean against the full live FDA warning-letter index. It runs about $199/month.
We weigh Layla the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Layla actually costs
- Compounded semaglutide — Injection: $199/mo
- Compounded tirzepatide — Injection: $299/mo
That's roughly in line with the ~$179/month median across our roster.
The medications Layla prescribes
Layla prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Layla fits — and where it doesn't — for mothers
Worth it if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Layla is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who can read past the countdown to the standing rate and wants a named prescribing practice behind the prescription.
Alternatives to Layla
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Layla
Head-to-head & alternatives
Layla, answered
- How much does Layla cost?
- When we last checked, the cheapest ongoing compounded price at Layla was around $199 a month: $199/mo for semaglutide and $299/mo for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is Layla safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to Layla as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does Layla offer both semaglutide and tirzepatide?
- Yes — Layla offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Layla rank for mothers?
- Layla takes 41/100 in our Editors' Rating, placing it #255. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect Layla's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.